This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $22,599.92, is for the supply of 4,566,593,499 units of the medication Ondansetron HCL 8 mg tablet. The contract has a completion date of December 4, 2024 and was awarded on December 3, 2022. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and does not have any set-aside designations for this contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/4/25, 11:34 AM